JASPER THERAPEUTICS INC

Jasper Therapeutics COO Buys Convertible Preferred Stock in Quiet Insider Move, Hinting at Future Upside and Strategic Alignment

Jasper Therapeutics COO’s purchase of 881 preferred shares signals strong leadership confidence, hinting at future value‑boosting conversions and strategic growth.

JASPER THERAPEUTICS INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

23/07/2026, 01:26

4 minutes to read

Jasper Therapeutics Sees Strategic Shift as Key Shareholder Patrick J. Crutcher Buys Options and Preferred Stock Ahead of Merger‑Driven Capital Raise

Jasper Therapeutics’ insider buys signal a strategic shift: Patrick Crutcher’s new options and preferred stock align with a $132 M merger, hinting at future growth and potential dilution for investors.

JASPER THERAPEUTICS INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

21/07/2026, 02:54

3 minutes to read